These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37560290)

  • 1. Impact of obesity on catheter ablation of ventricular tachycardia: In-hospital and 30-day outcomes.
    Tan MC; Yeo YH; Ang QX; Tan BE; Rattanawong P; Tan JL; Lee JZ
    J Arrhythm; 2023 Aug; 39(4):672-675. PubMed ID: 37560290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes, Costs, and 30-Day Readmissions After Catheter Ablation of Myocardial Infarct-Associated Ventricular Tachycardia in the Real World: Nationwide Readmissions Database 2010 to 2015.
    Cheung JW; Yeo I; Ip JE; Thomas G; Liu CF; Markowitz SM; Lerman BB; Kim LK
    Circ Arrhythm Electrophysiol; 2018 Nov; 11(11):e006754. PubMed ID: 30376735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of age on hospital outcomes after catheter ablation for ventricular tachycardia.
    Tan MC; Yeo YH; Ang QX; Kiwan C; Fatunde O; Lee JZ; Tolat A; Sorajja D
    J Arrhythm; 2024 Apr; 40(2):317-324. PubMed ID: 38586842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device.
    Aryana A; Gearoid O'Neill P; Gregory D; Scotti D; Bailey S; Brunton S; Chang M; d'Avila A
    Heart Rhythm; 2014 Jul; 11(7):1122-30. PubMed ID: 24732372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term outcomes associated with inpatient ventricular tachycardia catheter ablation.
    Sharma P; Tripathi B; Naraparaju V; Patel M; Bhagat A; Yerasi C; Kumar V; Aujla P; Singh G; Lahewala S; Arora S; Deshmukh A; Tolat A
    Pacing Clin Electrophysiol; 2020 May; 43(5):444-455. PubMed ID: 32196697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty-day readmission after catheter ablation for ventricular tachycardia: associated factors and outcomes.
    Tan MC; Ang QX; Yeo YH; Deshmukh A; Scott LR; Hussein AA; Sroubek J; Santangeli P; Wazni OM; Lee JZ
    J Interv Card Electrophysiol; 2024 Apr; 67(3):513-521. PubMed ID: 37530968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation compared to medical therapy for ventricular tachycardia in sarcoidosis: nationwide outcomes and hospital readmissions.
    Gurin MI; Xia Y; Tarabanis C; Goldberg RI; Knotts RJ; Donnino R; Reyentovich A; Bernstein S; Jankelson L; Kushnir A; Holmes D; Spinelli M; Park DS; Barbhaiya CR; Chinitz LA; Aizer A
    Am Heart J Plus; 2024 Aug; 44():100421. PubMed ID: 39070127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world characteristics and readmissions among patients undergoing ablation for ventricular tachycardia: a retrospective database analysis of commercially insured patients in the USA.
    Mehta V; Boo LM; Ghaly N; Kalsekar I; Zhang S; Yadalam S; Khanna R; Rahman M
    Open Heart; 2020 Sep; 7(2):. PubMed ID: 32998979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database.
    Aryana A; d'Avila A; Cool CL; Miller MA; Garcia FC; Supple GE; Dukkipati SR; Lakkireddy D; Bunch TJ; Bowers MR; O'Neill PG; Reddy VY; Marchlinski FE
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1295-1302. PubMed ID: 28800178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States.
    Palaniswamy C; Kolte D; Harikrishnan P; Khera S; Aronow WS; Mujib M; Mellana WM; Eugenio P; Lessner S; Ferrick A; Fonarow GC; Ahmed A; Cooper HA; Frishman WH; Panza JA; Iwai S
    Heart Rhythm; 2014 Nov; 11(11):2056-63. PubMed ID: 25016150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of catheter ablation for ventricular tachycardia in patients with sarcoidosis: Insights from the National Inpatient Sample database (2002-2018).
    Tan JL; Jin C; Lee JZ; Gaughan J; Iwai S; Russo AM
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2585-2598. PubMed ID: 36335632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of scar-based ventricular tachycardia: Relationship of procedure duration to outcomes and hospital mortality.
    Yu R; Ma S; Tung R; Stevens S; Macias C; Bradfield J; Buch E; Vaseghi M; Fujimura O; Gornbein J; Mandapati R; Shivkumar K; Boyle NG
    Heart Rhythm; 2015 Jan; 12(1):86-94. PubMed ID: 25285644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort.
    Yousuf OK; Zusterzeel R; Sanders W; Caños D; Dekmezian C; Silverman H; Calkins H; Berger R; Tandri H; Nazarian S; Strauss DG
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1189-1199. PubMed ID: 30236393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of catheter ablation of ventricular tachycardia: a single-center experience.
    Peichl P; Wichterle D; Pavlu L; Cihak R; Aldhoon B; Kautzner J
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):684-90. PubMed ID: 24958396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Ventricular Tachycardia Catheter Ablation in Patients Who Underwent Cardiac Defibrillator Implantation Nationwide Readmission Database Analysis.
    Moustafa A; Elzanaty A; Karim S; Eltahawy E; Kahaly O; Elbatanony L; Khalil M; Maraey A; Chacko P
    Am J Cardiol; 2023 Jul; 198():108-112. PubMed ID: 37188567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter Ablation of Ventricular Tachycardia in Patients With a Ventricular Assist Device: A Systematic Review of Procedural Characteristics and Outcomes.
    Anderson RD; Lee G; Virk S; Bennett RG; Hayward CS; Muthiah K; Kalman J; Kumar S
    JACC Clin Electrophysiol; 2019 Jan; 5(1):39-51. PubMed ID: 30678785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Versus Late Referral for Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease: A Systematic Review and Meta-Analysis of Clinical Outcomes.
    Romero J; Di Biase L; Diaz JC; Quispe R; Du X; Briceno D; Avendano R; Tedrow U; John RM; Michaud GF; Natale A; Stevenson WG; Kumar S
    JACC Clin Electrophysiol; 2018 Mar; 4(3):374-382. PubMed ID: 30089564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of Refractory Ventricular Tachycardia Using Intramyocardial Needle Delivered Heated Saline-Enhanced Radiofrequency Energy: A First-in-Man Feasibility Trial.
    Packer DL; Wilber DJ; Kapa S; Dyrda K; Nault I; Killu AM; Kanagasundram A; Richardson T; Stevenson W; Verma A; Curley M;
    Circ Arrhythm Electrophysiol; 2022 Aug; 15(8):e010347. PubMed ID: 35776711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT).
    Tung R; Josephson ME; Reddy V; Reynolds MR;
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):799-803. PubMed ID: 20132389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.
    Kanagaratnam A; Virk SA; Pham T; Anderson RD; Turnbull S; Campbell T; Bennett R; Thomas SP; Lee G; Kumar S
    Heart Lung Circ; 2022 Aug; 31(8):1064-1074. PubMed ID: 35643798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.